Capital Management Corp VA Invests $5.07 Million in LifeVantage Co. (NASDAQ:LFVN)

Capital Management Corp VA purchased a new stake in LifeVantage Co. (NASDAQ:LFVN) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 419,930 shares of the company’s stock, valued at approximately $5,073,000. Capital Management Corp VA owned 3.31% of LifeVantage as of its most recent filing with the Securities & Exchange Commission.

Other large investors also recently made changes to their positions in the company. Vanguard Group Inc. boosted its position in LifeVantage by 2.8% during the 1st quarter. Vanguard Group Inc. now owns 475,021 shares of the company’s stock worth $2,874,000 after purchasing an additional 12,809 shares during the period. Renaissance Technologies LLC boosted its position in shares of LifeVantage by 2.1% in the second quarter. Renaissance Technologies LLC now owns 855,118 shares of the company’s stock worth $5,490,000 after buying an additional 17,300 shares during the period. Empowered Funds LLC grew its stake in shares of LifeVantage by 8.1% in the first quarter. Empowered Funds LLC now owns 76,203 shares of the company’s stock valued at $461,000 after buying an additional 5,742 shares in the last quarter. Ritholtz Wealth Management raised its holdings in shares of LifeVantage by 62.0% during the 3rd quarter. Ritholtz Wealth Management now owns 28,666 shares of the company’s stock valued at $346,000 after buying an additional 10,974 shares during the period. Finally, Acadian Asset Management LLC lifted its position in LifeVantage by 2.8% during the 1st quarter. Acadian Asset Management LLC now owns 228,088 shares of the company’s stock worth $1,378,000 after acquiring an additional 6,121 shares in the last quarter. Institutional investors and hedge funds own 35.32% of the company’s stock.

LifeVantage Stock Up 3.8 %

NASDAQ LFVN opened at $13.50 on Tuesday. The stock has a market cap of $169.09 million, a PE ratio of 42.19 and a beta of 0.84. The business has a 50 day moving average price of $11.12 and a two-hundred day moving average price of $8.50. LifeVantage Co. has a fifty-two week low of $4.20 and a fifty-two week high of $14.71.

LifeVantage (NASDAQ:LFVN) last released its quarterly earnings results on Tuesday, October 29th. The company reported $0.15 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.15. LifeVantage had a net margin of 2.11% and a return on equity of 29.24%. The business had revenue of $47.21 million during the quarter.

LifeVantage Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, December 16th. Investors of record on Monday, December 2nd will be paid a $0.04 dividend. This represents a $0.16 annualized dividend and a dividend yield of 1.19%. The ex-dividend date is Monday, December 2nd. LifeVantage’s dividend payout ratio (DPR) is 50.00%.

LifeVantage Profile

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.